EUVIMEDEUVIMED entdecken
Crossref

Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly

Mei Luo, Jiangfan Yu, Rui Tang

Journal of Neuro-Oncology · 2024

DOI: 10.1007/s11060-024-04620-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Neuro-Oncology, 2024. Verfasst von Mei Luo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, The Second Xiangya Hospital of Central South University, 410011, Changsha, Hunan, China. Hauptthemen laut MEDLINE: Acromegaly, Receptors, Somatostatin. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 48 Literaturangaben. Gefördert von: the Hunan Provincial Natural Science Foundation of China, the National Natural Science Foundation of China, the Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AcromegalyReceptors, SomatostatinAdultAgedFemaleHumansMaleMiddle AgedB7-H1 AntigenBiomarkers, TumorCD8-Positive T-LymphocytesDrug Resistance, NeoplasmFollow-Up StudiesGrowth Hormone-Secreting Pituitary AdenomaLigandsOctreotidePrognosisRetrospective Studies

Stichwörter der Autor:innen

AcromegalyCD8 + T cellPD-L1ResistanceSomatostatin receptor ligandSomatotropinoma

Substanzen

B7-H1 AntigenBiomarkers, TumorLigandsOctreotideReceptors, Somatostatin

Autor:innen und Institutionen

  • Department of Neurosurgery, The Second Xiangya Hospital of Central South University, 410011, Changsha, Hunan, China.
  • Department of Neurosurgery and Pituitary Tumor Center, The First Affiliated Hospital, Sun Yat-Sen University, Guangzhou, China.
  • Department of Pediatric Dermatology, Dermatology Hospital of Southern Medical University, 510091, Guangzhou, China.
  • Department of Rheumatology and Immunology, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. tangrui@csu.edu.cn.
  • Clinical Medical Research Center for Systemic Autoimmune Diseases, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China. tangrui@csu.edu.cn.

Förderung

  • the Hunan Provincial Natural Science Foundation of China
  • the National Natural Science Foundation of China
  • the Scientific Research Launch Project for new employees of the Second Xiangya Hospital of Central South University

Zitieren

APA

Luo, M., Yu, J., & Tang, R. (2024). Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly. Journal of Neuro-Oncology. https://doi.org/10.1007/s11060-024-04620-7

Vancouver

Luo M, Yu J, Tang R. Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly. Journal of Neuro-Oncology. 2024. doi:10.1007/s11060-024-04620-7

BibTeX
@article{Luo2024,
  author = {Luo, Mei and Yu, Jiangfan and Tang, Rui},
  title = {Immunological signatures and predictive biomarkers for first-generation somatostatin receptor ligand resistance in Acromegaly},
  journal = {Journal of Neuro-Oncology},
  year = {2024},
  doi = {10.1007/s11060-024-04620-7}
}
Kostenlos starten →